In breast cancer in particular, FISH assays for the assessment of HER2 (ERBB2) gene status on chromosome (chr) 17q12 are used as in vitro diagnostic devices (IVD), based on the well established clinical utility of this marker for selecting patients who will benefit from trastuzumab treatment. Here, ERBB2 is linked to breast cancer.